PubRank

Laura J Balcer

Author PubWeight™ 104.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006 4.72
2 Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011 3.48
3 Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010 2.96
4 Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012 2.79
5 Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012 2.48
6 Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007 2.44
7 The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci 2011 2.43
8 In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013 2.43
9 Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 2013 2.22
10 Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008 2.20
11 Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 2013 2.06
12 Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. Arch Neurol 2002 2.05
13 Laser pointer visual field screening. J Neuroophthalmol 2003 2.03
14 Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol 2009 1.85
15 Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol 2011 1.80
16 Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol 2006 1.66
17 Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics 2011 1.57
18 Near infrared muscle spectroscopy in patients with Friedreich's ataxia. Muscle Nerve 2002 1.53
19 Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS. Neurology 2012 1.51
20 Functional visual loss in idiopathic intracranial hypertension. Ophthalmology 2009 1.51
21 Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology 2013 1.46
22 Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies. J AAPOS 2011 1.45
23 Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. Brain 2010 1.45
24 The role of unilateral temporal artery biopsy. Ophthalmology 2003 1.44
25 Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol 2009 1.43
26 Optic nerve biopsy in the management of progressive optic neuropathy. J Neuroophthalmol 2012 1.37
27 Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 2007 1.37
28 In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 2012 1.36
29 Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology 2013 1.36
30 Sports-related concussion: Anonymous survey of a collegiate cohort. Neurol Clin Pract 2013 1.35
31 Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 2010 1.29
32 Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord 2010 1.29
33 Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 2012 1.27
34 The Neurological Complications of Nutritional Deficiency following Bariatric Surgery. J Obes 2012 1.27
35 Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 2011 1.25
36 Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 2008 1.25
37 Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol 2008 1.20
38 One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol 2011 1.17
39 Saccades and memory: baseline associations of the King-Devick and SCAT2 SAC tests in professional ice hockey players. J Neurol Sci 2013 1.14
40 Predictors of future publication record and academic rank in a cohort of neurology residents. Neurology 2006 1.13
41 Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma. Ann Neurol 2014 1.12
42 Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009 1.11
43 Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol 2010 1.10
44 The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 2011 1.09
45 Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol 2011 1.07
46 Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment. J Neurol Sci 2004 1.04
47 Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nat Rev Neurol 2010 1.01
48 Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol 2002 0.95
49 Antioxidant use in Friedreich ataxia. J Neurol Sci 2007 0.95
50 Performance measures in Friedreich ataxia: potential utility as clinical outcome tools. Mov Disord 2005 0.95
51 Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord 2003 0.91
52 Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study. J Neuroophthalmol 2012 0.90
53 Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. J Neuroophthalmol 2002 0.90
54 Adding Vision to Concussion Testing: A Prospective Study of Sideline Testing in Youth and Collegiate Athletes. J Neuroophthalmol 2015 0.89
55 Health related quality of life measures in Friedreich Ataxia. J Neurol Sci 2008 0.87
56 Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 2011 0.86
57 Retinal damage and vision loss in African American multiple sclerosis patients. Ann Neurol 2015 0.84
58 Combined optic neuropathy and myelopathy secondary to copper deficiency. Surv Ophthalmol 2010 0.83
59 Analysis of the visual system in Friedreich ataxia. J Neurol 2013 0.83
60 Pituitary apoplexy causing optic neuropathy and horner syndrome without ophthalmoplegia. J Neuroophthalmol 2003 0.82
61 Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis. J Neuroophthalmol 2013 0.82
62 The latest on optical coherence tomography. J Neuroophthalmol 2014 0.80
63 Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci 2010 0.79
64 Sports-related concussion testing. Curr Neurol Neurosci Rep 2012 0.79
65 Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis. Mult Scler 2013 0.79
66 Diagnostic tests for concussion: is vision part of the puzzle? J Neuroophthalmol 2015 0.78
67 The neuro-ophthalmology of multiple sclerosis. Continuum (Minneap Minn) 2010 0.78
68 Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life. J Neuroophthalmol 2015 0.78
69 Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography. Am J Ophthalmol 2006 0.78
70 Current concepts in pseudotumor cerebri. Curr Opin Neurol 2016 0.78
71 Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst 2011 0.77
72 Optic neuritis and the evaluation of visual impairment in multiple sclerosis. Continuum (Minneap Minn) 2013 0.77
73 Residency training: the King-Devick test and sleep deprivation: study in pre- and post-call neurology residents. Neurology 2012 0.77
74 Approach to optic neuropathies: clinical update. Neurologist 2010 0.77
75 Multiple sclerosis and the ophthalmologist. Compr Ophthalmol Update 2007 0.77
76 20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought? J Neuroophthalmol 2016 0.76
77 Objective characterization of the relative afferent pupillary defect in MS. J Neurol Sci 2012 0.76
78 Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia. Alzheimer Dis Assoc Disord 2016 0.76
79 In reply: the King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort. J Neurol Sci 2013 0.75
80 Education research: a new system for reducing patient nonattendance in residents' clinic. Neurology 2010 0.75
81 Tension pneumocephalus after endoscopic sinus surgery: case report of repair and management in absence of obvious skull base defect. Ear Nose Throat J 2008 0.75
82 All choked up about the pseudotumor cerebri syndrome. Neurology 2013 0.75
83 The 56th annual meeting of the American Academy of Neurology, San Francisco, California, April 24-30, 2004. J Neuroophthalmol 2004 0.75
84 OCT and NMO: are there methods to our madness? J Neuroophthalmol 2013 0.75
85 Tumoral Presentation of Homonymous Hemianopia and Prosopagnosia in Cerebral Amyloid Angiopathy-Related Inflammation. J Neuroophthalmol 2017 0.75
86 Pupil-involving third nerve palsy as a manifestation of anti-myelin-associated glycoprotein neuropathy. J Neuroophthalmol 2011 0.75
87 Visual Structure and Function in Collision Sport Athletes. J Neuroophthalmol 2017 0.75
88 Endocrine and metabolic deficiency. Ophthalmol Clin North Am 2004 0.75
89 The 57th Annual Meeting of the American Academy of Neurology, Miami, Florida, April 9-16, 2005. J Neuroophthalmol 2005 0.75
90 Fear sensitivity and the psychological profile of patients with psychogenic nonepileptic seizures. Epilepsy Behav 2006 0.75
91 Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort. J Neuroophthalmol 2017 0.75
92 54th annual meeting of the American Academy of Neurology, Denver, Colorado, April 13-20, 2002. J Neuroophthalmol 2003 0.75